Fexofenadine Hydrochloride

6 trials 5 recruiting RRespiratory

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

5 Recruiting

1 Completed trials

5 Sponsors

12 Countries

Phase III

Phase II/III

Phase II

Phase I (FiH)

Phase III: 3 Phase II/III: 1 Phase II: 1 Phase I (FiH): 1

Oversight events:

4 temporary halts 1 urgent safety measure across 2 trials

View oversight register →

Indications tested

Epidermolysis bullosa 1 Systemic mastocytosis 1 Methylmalonic aciduria 1

Sponsors using this IMP

Inmunotek S.L. 2 Medical University Of Gdansk 1 Medical University Of Vienna 1 Moderna Inc. 1 Rheacell GmbH & Co. KG 1

All trials

6 total

Phase III clinical trial of ABCB5+ MSCs for the treatment of EB Recruiting

2022-500266-10-00 Phase III 12 countries Rheacell GmbH & Co. KG
H1-antihistaminE treatment in combiNation with immunotHerapy in pAtieNts with advanced non small cell lung canCEr: A single- center phase -E… Recruiting

2024-518633-28-00 Phase II 1 country Medical University Of Vienna
A prospective, randomized, double-blind, placebo-controlled, multicentre, dose-finding clinical trial with polymerised mannan-conjugated all… Recruiting

2025-524580-21-00 Phase II/III 1 country Inmunotek S.L.
The use of dupilumab in treatment of indolent systemic mastocytosis with skin involvement Recruiting

2023-509111-89-00 Phase III 1 country Medical University Of Gdansk
Phase 1/2 study of mRNA-3705 in participants with Isolated MMA (Extension Study). Recruiting

2022-501997-20-00 Phase I (FiH) 3 countries Moderna Inc.
A prospective, randomized, double-blind placebo-controlled multicentre trial with mannan-conjugated birch pollen allergoids administered sub… Ended

2024-515717-17-00 Phase III 1 country Inmunotek S.L.

Showing 1–6 of 6 trials

← All drugs A–Z